INTERNATIONAL PATENT: SHENNON BIOTECHNOLOGIES INC. FILES APPLICATION FOR "ENGINEERED IMMUNE CELLS AND USES THEREOF"

GENEVA, Dec. 24 -- SHENNON BIOTECHNOLOGIES INC. (2325 3rd StreetSuite 327-328San Francisco, California 94107) filed a patent application (PCT/US2025/032860) for "ENGINEERED IMMUNE CELLS AND USES THEREOF" on Jun 09, 2025. With publication no. WO/2025/259591, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Kaitao (2325 3rd StreetSuite 327-328San Francisco, California 94107)

Abstract: Provided herein are compositions and methods that include engineered immune cells (e.g., engineered T cells) with reduced expression of e...